Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Shanghai Junshi Biosciences Co., Ltd. Class H
1877Health technology
$4.7B
Market Cap
Shariah Analysis
TBD
Business
Cash
Liabilities
Based on AAOIFI screening standards, Shanghai Junshi Biosciences Co., Ltd. Class H appears to be TBD.
Business Activity
Revenue breakdown data currently unavailable.
Financial Screening
FYE 2024
Cash (<30%)27.98%
Non-Shariah Cash Items
Cash And Cash Equivalents$2.5B
Other Short Term Investments$430.5M
Restricted Cash$15.5M
Liabilities (<30%)27.97%
Non-Shariah Liabilities
Current Capital Lease Obligation$30.3M
Long Term Debt$2B
Long Term Capital Lease Obligation$26.3M
Current Debt$894.6M
Market Data
Exchange
HKEX
CurrencyUSD
CountryHong Kong
Last Updated2025-12-15
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
HKEX
